Loading...
OTCM
PHCCF
Market cap1.06bUSD
Jul 03, Last price  
11.30USD
Name

PHC Holdings Corp

Chart & performance

D1W1MN
OTCM:PHCCF chart
P/E
461.74
P/S
0.62
EPS
3.87
Vol. 1Y
—
Shs. 5Y
0.82%
Rev. 5Y
3.55%
Div Yld LY
—
Div Yld TTM
—
Revenues
364.40b
+0.78%
186,546,000,000272,637,000,000306,071,000,000340,452,000,000356,434,000,000353,900,000,000361,593,000,000364,403,000,000
Net income
492m
-95.31%
15,453,000,0005,277,000,00016,906,000,000-8,460,000,000-3,221,000,000-12,892,000,00010,484,000,000492,000,000
CFO
42.46b
+1.23%
33,790,000,00036,865,000,00047,850,000,00051,053,000,00021,376,000,00041,304,000,00041,941,000,00042,458,000,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PHC Holdings Corporation, through its network of subsidiaries, specializes in the innovation, production, and sale of medical instruments, advanced healthcare technology solutions, and life science merchandise. The company's product line includes blood glucose monitoring systems and a variety of other diagnostic and analytical tools, alongside sophisticated data integration platforms. It also delivers end-to-end anatomical pathology solutions, featuring specialized equipment, microscope slides, and diverse staining reagents. In the life sciences sector, PHC provides essential equipment and support services for sample preservation and cell culture. Furthermore, the company develops and deploys healthcare IT products, focusing on medical information systems designed for clinics and pharmacies dealing with health insurance. Its operations also extend to clinical testing, the manufacturing of diagnostic reagents, and providing support for pharmaceutical development. Established in 2014 and based in Tokyo, Japan, the company was formerly recognized as Panasonic Healthcare Holdings Co., Ltd. before officially changing its name to PHC Holdings Corporation in April 2018.

Key people

Kaiju Yamaguchi
Managing Executive Officer, Chief Financial Officer · since 2024
Ryuichi Hirashima
Senior Managing Executive Officer, Chief Human Resources Officer, Chief Administrative Officer, Chief Transformation Officer · since 2022
Nobuaki Nakamura
Managing Executive Officer, Manager of Diagnostics and Life Sciences Domain · since 2024
Steven Lynum
Executive Officer, Manager of Diagnostics and Life Sciences Co-Domain
Robert Schumm
Executive Officer, Director of BGM Business · since 2024
Hideaki Takahashi
Executive Officer, Director of Healthcare IT Solution Business · since 2024
Chikara Takauo
Executive Officer, Director of Biomedical Business · since 2024
Kenichi Uchino
Executive Officer, Director of LSIM Business · since 2024
Kyoko Deguchi
President, Chief Executive Officer, Representative Director · since 2024
Koichiro Sato
Vice President, Chief Operating Officer, Chief Strategy Officer, Manager of Diabetes Management Domain, Manager of Healthcare Solutions Domain, Representative Director · since 2024
Yoshiki Yamaguchi
Director · since 2025
Hirofumi Hirano
Independent Director · since 2013
Independent Director · since 2022
Independent Director · since 2021
Misa Yamashita
Independent Director · since 2024
Eiji Yatagawa
Independent Director · since 2022
IPO date
Oct 14, 2021
Employees
9,403
Domiciled in
JP
Incorporated in
JP
Headquarters & legal address
有楽町一丁目13番2号
東京都 千代田区 100-8403
JP
Address
1-13-2, Yuraku-cho
Chiyoda-ku Tokyo 100-8403
JP
Other language
PHC Holdings Corporation

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT